Pharmaceuticals
Company Overview of Cambria Pharmaceuticals, Inc.
Company Overview
Cambria Pharmaceuticals, Inc. operates as a biopharmaceutical company and discovers and develops treatments for disabling neurological disorders. It focuses on molecule drugs for neurological conditions, such as amyotrophic lateral sclerosis, muscular dystrophy, and Parkinson's disease. The company was formerly known as Cambria Biosciences LLC and changed its name to Cambria Pharmaceuticals, Inc. in April, 2008. The company was founded in 1998 and is based in Woburn, Massachusetts.
8A Henshaw Street
Woburn, MA 01801
United States
Founded in 1998
Key Executives for Cambria Pharmaceuticals, Inc.
Similar Private Companies By Industry
| Company Name | Region |
| Shire Development Inc. | United States |
| Pharmacia & Upjohn, Inc. | United States |
| MicroReactor Technologies, Inc. | United States |
| Palm Beach Rejuvenation Centres Inc. | United States |
| Wyeth Pharmaceuticals, Inc. | United States |
Recent Private Companies Transactions
| Type Date |
Target | |
| No transactions available in the past 12 months. | ||
Most Searched Private Companies
| Company Name | Geographic Region |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| NYC2012, Inc. | United States |
| Rush University | United States |
| Citizens Budget Commission | United States |
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- New Brunswick, NJ | Tridiagonal SolutionsPosted: Apr 24
- Atlantic City, NJ | Pat Licata & AssociatesPosted: May 19
- Souderton, PA | Hire IT PeoplePosted: May 18
Sponsored Financial Commentaries
Sponsored Links
To contact Cambria Pharmaceuticals, Inc., please visit www.cambriabio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
